{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:30:14Z","timestamp":1761755414447,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ajp.2017.01.011","type":"journal-article","created":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T14:45:46Z","timestamp":1484837146000},"page":"152-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Use of zuclopenthixol in the treatment of aggression in Huntington\u2019s disease"],"prefix":"10.1016","volume":"26","author":[{"given":"Prashant","family":"Tibrewal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarun","family":"Bastiampillai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohan","family":"Dhillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Tanuje","family":"Fonseka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ajp.2017.01.011_bib0005","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11920-996-0030-2","article-title":"An overview of psychiatric symptoms in Huntington\u2019s disease","volume":"3","author":"Anderson","year":"2001","journal-title":"Curr. Psychiatry Rep."},{"issue":"1","key":"10.1016\/j.ajp.2017.01.011_bib0010","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1212\/WNL.38.1.84","article-title":"Serum haloperidol concentration and choreiform movements in Huntington\u2019s disease","volume":"38","author":"Barr","year":"1988","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ajp.2017.01.011_bib0015","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/hmg\/ddn033","article-title":"Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant huntingtin through the regulation of mitochondrial complex II","volume":"17","author":"Benchoua","year":"2008","journal-title":"Hum. Mol. Gen."},{"key":"10.1016\/j.ajp.2017.01.011_bib0020","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.nbd.2007.07.028","article-title":"Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtun in vivo","volume":"29","author":"Charvin","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ajp.2017.01.011_bib0025","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3233\/JHD-140127","article-title":"Aggression in Huntington\u2019s disease: a systematic review of rates of aggression and treatment methods","volume":"3","author":"Fisher","year":"2014","journal-title":"J. Huntington\u2019s Dis."},{"key":"10.1016\/j.ajp.2017.01.011_bib0030","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/jnnp.47.8.848","volume":"47","author":"Girotti","year":"1984","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ajp.2017.01.011_bib0035","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1164\/rccm.2107138","article-title":"The Richmond agitation-Sedation scale: validity and reliability in adult intensive care unit patients","volume":"166","author":"Sessler","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ajp.2017.01.011_bib0040","first-page":"1","article-title":"Antipsychotic drugs in Huntington\u2019s disease","author":"Unti","year":"2016","journal-title":"Expert Rev. Neurother."}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201816303811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201816303811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:27:24Z","timestamp":1761755244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201816303811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":8,"alternative-id":["S1876201816303811"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2017.01.011","relation":{},"ISSN":["1876-2018"],"issn-type":[{"type":"print","value":"1876-2018"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of zuclopenthixol in the treatment of aggression in Huntington\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2017.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}